Miraculins Announces Thermo Fisher Scientific as Key Manufacturing Partner
September 22, 2011
Miraculins Inc. (TSX-V:MOM), a medical diagnostic company focused on developing and commercializing diagnostic tests and risk assessment tools for unmet clinical needs is pleased to announce that it has completed an Exclusive Manufacturing and Supply Agreement with Thermo Fisher Scientific Inc., the world leader in serving science. Under the agreement, Thermo Fisher will supply the [...]
September 22, 2011
CARLSBAD, Calif. -- Life Technologies Corporation (NASDAQ:LIFE) today announced that the company has signed an agreement with Quidel Corporation to distribute and commercialize molecular diagnostic assays for the European market. The deal represents Life's continued growth into the diagnostics space. "About ten percent of Life Technologies' current revenues derive from molecular diagnostics," said Kim Caple, [...]
PrimeraDx Appoints Albert A. Luderer to its Board of Directors
September 22, 2011
MANSFIELD, Mass. -- PrimeraDx today announced that Albert Luderer has been appointed to its Board of Directors. President and CEO Matthew McManus commented: "We are excited to have Al join our board at this pivotal time. We have just launched the ICEPlex System, which is the first molecular diagnostics system that is capable of high [...]
Izon Science Opens New US Headquarters in Cambridge, Massachusetts
September 22, 2011
Cambridge, MA and Christchurch, New Zealand - Nanotechnology instrument manufacturer Izon Science officially opened the company’s new U.S. headquarters in Cambridge, Massachusetts today to further support their expanding client base in 23 countries. The new office is located at One Kendall Square in Cambridge. Hans van der Voorn, Executive Chairman of Izon Science, said, “Locating [...]
September 22, 2011
A team of researchers from Roche, including scientists from Roche Pharma Research and Early Development and Roche NimbleGen, reported in Genome Research (1) that they have generated the first draft genome sequence of the cynomolgus monkey (Macaca fascicularis) and developed a novel microarray design for in depth expression profiling for use in preclinical drug safety [...]
September 22, 2011
DENVER--Accelr8 Technology Corporation (NYSE Amex: AXK) announced that Accelr8 and SCHOTT Technical Glass Solutions, GmbH (Jena, Germany) have renewed Accelr8’s license to SCHOTT for Nexterion® microarraying slides using OptiChem® biocoatings. In addition to renewing the existing non-exclusive license, Accelr8 also granted to SCHOTT the right to sell OptiChem®-coated products for application in medical diagnostics. Previously, [...]
Neogen Launches Fully Quantitative Lateral Flow Test for Aflatoxin
September 22, 2011
LANSING, Mich.-- Neogen Corporation (NASDAQ: NEOG) has developed a quick and easy new test for aflatoxin, a toxin considered by many to be the most potent, naturally-occurring carcinogen. The toxin is a by-product of mold growth in a wide range of commodities, including corn. Because it is a known severe threat to human and animal [...]
Kimble Chase is Making Scientific Discovery More Accessible
September 21, 2011
Performing chemical experiments in microscale is easier with specialized kits from Kimble Chase, the largest manufacturer of laboratory glassware products in the world. Williamson microscale kits offer a selection of specially tooled laboratory glassware with patented thermoplastic connectors to allow quick, easy and secure connections. Other available kits feature components with GCI threads or 14/10 [...]
NanoString Introduces Solution for Simultaneously Measuring miRNA and mRNA Expression Levels
September 21, 2011
SEATTLE--NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the availability of the nCounter® miRGE Assay for use on its nCounter Analysis System. The nCounter miRGE (“merge”) Assay enables researchers to investigate expression levels of both micro RNAs (miRNAs) and the messenger RNAs [...]
September 21, 2011
CAMBRIDGE, Mass. -- IntelligentMDx (IMDx) announced today that it has received CE-Mark for its second automated molecular test for the Abbott FDA cleared m2000 instrument. The IMDx™ VanR for Abbott m2000™ test accurately detects and distinguishes the vanA and vanB genes most commonly found in vancomycin-resistant enterococci (VRE) in specimens from patients at risk for [...]